Abstract

Although in vitro sensors provide facile low-cost ways to screen for biologically active targets, their results may not accurately represent the molecular interactions in biological systems. Cell-based sensors have emerged as promising platforms to screen targets in biologically relevant environments. However, there are few examples where cell-based sensors have been practically applied for drug screening. Here, we used engineered cortisol-detecting sensor cells to screen for natural mimetics of cortisol. The sensor cells were designed to report the presence of a target through signal peptide activation and subsequent fluorescence signal translocation. The developed sensor cells were able to detect known biological targets from human-derived analytes as well as natural product extracts, such as deer antlers and ginseng. The multi-use capability and versatility to screen in different cellular environments were also demonstrated. The sensor cells were used to identify novel GR effectors from medicinal plant extracts. Our results suggest that decursin from dongquai had the GR effector function as a selective GR agonist (SEGRA), making it a potent drug candidate with anti-inflammatory activity. We demonstrated the superiority of cell-based sensing technology over in vitro screening, proving its potential for practical drug screening applications that leads to the function-based discovery of target molecules.

Highlights

  • Reported sensing probes constructed with glucocorticoid receptor (GR) as a target recognition element and inactivated split-signal peptides conjugated to fluorescent cargo as a reporter element were used in this study [11]

  • Cell-based sensors are a promising platform for various applications that require the screening of targets in their native environment

  • Sensor cells have often been utilized for the spatiotemporal analysis of molecular interactions and their dynamics [51,52]

Read more

Summary

Introduction

There is always a strong need for improved analytical strategies that can offer new avenues to screen for molecules of interest [1,2]. Current approaches to screen drug candidates are often based on in vitro competitive binding assays and immunoassays [3,4,5,6]. These in vitro assays offer facile low-cost ways of screening, they have some limitations. Screening analytes based on their biological functions in their native working environment is essential to effectively identify drug candidates

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call